LONDON, Aug 15 (Reuters) – Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.
The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by U.S. drug company Moderna (MRNA.O) conditional approval as a booster for adults on Monday.
Britain’s Joint Committee on Vaccination and Immunisation (JCVI) is now expected to issue a recommendation soon on how the vaccine should be deployed in the country.
